Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
The enterprise value (EV) is $1.12M.
ENTERPRISE VALUE (EV)
$1.12M
Pulmatrix, Inc.
Market Cap
$5.20M
Enterprise Value (EV)
$1.12M
| NAME | MARKET CAP | ENTERPRISE VALUE (EV) |
|---|---|---|
| Pulmatrix, Inc. (PULM) | $5.20M | $1.12M |
| Alzamend Neuro Inc (ALZN)vs › | $5.23M | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.17M | $3.42M |
| Lexaria Bioscience Corp. (LEXX)vs › | $5.16M | $1.77M |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.28M | $8.68M |
| Intelligent Bio Solutions Inc. (INBS)vs › | $5.31M | $3.13M |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.08M | $3.50M |
| Soligenix, Inc. (SNGX)vs › | $5.33M | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.06M | $11.68M |
| Xenetic Biosciences, Inc. (XBIO)vs › | $5.02M | N/A |
Market Cap
$5.20M
Total Debt
$0.00
Cash
$4.09M
Enterprise Value
$1.12M
Why use EV instead of Market Cap?
Enterprise Value represents the total value of a company as if you were to acquire it completely - paying for equity while assuming debt and receiving cash.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
